Nova Eye Medical Limited
Nova Eye Medical Limited (ELXMF) Financial Performance & Income Statement Overview
View comprehensive annual and quarterly summaries for Nova Eye Medical Limited (ELXMF), featuring income statements, balance sheets, and cash flow data.
Nova Eye Medical Limited (ELXMF) Income Statement & Financial Overview
View the income breakdown for Nova Eye Medical Limited ELXMF across both annual and quarterly reports.
| Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 |
|---|---|---|---|---|
| Revenue | $13.19M | $10.14M | $8.63M | $8.39M |
| Cost of Revenue | $1.93M | $8.82M | $7.21M | $8.98M |
| Gross Profit | $11.26M | $1.32M | $1.43M | -$586000.00 |
| Gross Profit Ratio | $0.85 | $0.13 | $0.17 | -$0.07 |
| R&D Expenses | $567000.00 | $0.00 | $617000.00 | $0.00 |
| SG&A Expenses | $11.48M | $6.93M | $4.09M | $6.65M |
| Operating Expenses | $12.05M | $6.93M | $6.06M | $6.42M |
| Total Costs & Expenses | $13.97M | $15.74M | $13.27M | $15.39M |
| Interest Income | $73000.00 | $51000.00 | $68000.00 | $35000.00 |
| Interest Expense | $58000.00 | $12000.00 | $25000.00 | $29000.00 |
| Depreciation & Amortization | $1.57M | $1.42M | $1.18M | $1.11M |
| EBITDA | -$1.54M | -$4.18M | -$3.36M | -$5.89M |
| EBITDA Ratio | -$0.12 | -$0.41 | -$0.40 | -$0.70 |
| Operating Income | -$786000.00 | -$5.61M | -$4.63M | -$7.004M |
| Operating Income Ratio | -$0.06 | -$0.55 | -$0.54 | -$0.83 |
| Other Income/Expenses (Net) | -$2.38M | -$19000.00 | -$6.91M | -$30000.00 |
| Income Before Tax | -$3.17M | -$5.63M | -$9.97M | -$7.03M |
| Income Before Tax Ratio | -$0.24 | -$0.55 | -$1.15 | -$0.84 |
| Income Tax Expense | $0.00 | $0.00 | -$1.28M | -$429000.00 |
| Net Income | -$3.17M | -$5.63M | -$8.69M | -$6.61M |
| Net Income Ratio | -$0.24 | -$0.55 | -$1.006 | -$0.79 |
| EPS | -$0.01 | -$0.03 | -$0.05 | -$0.04 |
| Diluted EPS | -$0.01 | -$0.03 | -$0.05 | -$0.04 |
| Weighted Avg Shares Outstanding | $217.03M | $195.77M | $169.12M | $149.74M |
| Weighted Avg Shares Outstanding (Diluted) | $217.60M | $195.77M | $169.12M | $149.74M |
Over the last four quarters, Nova Eye Medical Limited achieved steady financial progress, growing revenue from $8.39M in Q2 2023 to $13.19M in Q4 2024. Gross profit stayed firm with margins at 85% in Q4 2024 versus -7% in Q2 2023. Operating income totaled -$786000.00 in Q4 2024, maintaining a -6% margin over recent quarters. Despite shifts in R&D and SG&A costs, EBITDA stayed strong at -$1.54M. Net income rose to -$3.17M, with EPS at -$0.01. Disciplined expense strategies and efficient operations ensured sustained profitability and long-term financial stability.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan